United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 6 minute read Pharma Industry News FDA approves Ligand Partner SQ Innovation’s Lasix ONYU for heart failure edema—at-home use marks major shift in care Find out how Ligand and SQ Innovation’s FDA-approved Lasix ONYU is redefining heart-failure treatment with the first at-home edema therapy. bySoujanya RaviOctober 9, 2025